JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE & TASE: TEVA) announced today
a comprehensive restructuring plan to significantly reduce its cost
base, unify and simplify its organization and improve business
performance, profitability, cash flow generation and productivity.
Kåre Schultz, Tevas President and CEO, said, “Two weeks ago we
announced a new organizational structure and executive management team.
Today we are launching a comprehensive restructuring plan, crucial to
restoring our financial security and stabilizing our business. We are
taking immediate and decisive actions to reduce our cost base across our
global …
Read the full article at: https://www.businesswire.com/news/home/20171214005653/en/Teva-Announces-Restructuring-Plan-Additional-Measures-Improve